Trade Mark Journal No.2025/044 31 October 2025

WO0000001880893 (5)

Office of origin: United States of America

Date of International Registration:16 September 2025
Date of designation in the UK: 16 September 2025
Image for mark 1880893 ESENOVAX

International priority date claimed: 25 March 2025 (United States of America) (99102511)
Class 5
Medicinal preparations for the treatment and prevention of cancer and infectious diseases; biological preparations for the treatment and prevention of cancer and infectious diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the prevention of infectious diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention of cancer; vaccines.

ImmunityBio, Inc.

Representative: Alicia M. Passerin Leech Tishman Fuscaldo & Lampl, 525 William Penn Place, 28th Floor, Pittsburgh PA 15219, UNITED STATES OF AMERICA